Pharma Could Face Fewer False Claims Act Suits If Supreme Court Concurs With Government

High court is to determine whether the government can dismiss an FCA complaint after initially declining to take it on. In recent years, the government has dismissed numerous qui tam suits against pharma companies in which it did not intervene.

Supreme Court building
Supreme Court to hear oral argument on government's ability to seek dismissal of False Claims Act suits • Source: Shutterstock

More from Compliance

More from Pink Sheet